ADC Therapeutics SA banner

ADC Therapeutics SA
NYSE:ADCT

Watchlist Manager
ADC Therapeutics SA Logo
ADC Therapeutics SA
NYSE:ADCT
Watchlist
Price: 3.86 USD -4.46% Market Closed
Market Cap: $478.2m

Wall Street
Price Targets

ADCT Price Targets Summary
ADC Therapeutics SA

Wall Street analysts forecast ADCT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ADCT is 8.16 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

Lowest
Price Target
5.05 USD
31% Upside
Average
Price Target
8.16 USD
111% Upside
Highest
Price Target
10.5 USD
172% Upside
ADC Therapeutics SA Competitors:
Price Targets
QLYS
Qualys Inc
48% Upside
PTCT
PTC Therapeutics Inc
36% Upside
SANA
Sana Biotechnology Inc
168% Upside

Revenue
Forecast

85% / Year
Past Growth
53% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss
85% / Year
Past Growth
53% / Year
Estimated Growth
Estimates Accuracy
-1%
Average Miss

For the last 7 years the compound annual growth rate for ADC Therapeutics SA's revenue is 85%. The projected CAGR for the next 3 years is 53%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ADCT's stock price target?
Price Target
8.16 USD

According to Wall Street analysts, the average 1-year price target for ADCT is 8.16 USD with a low forecast of 5.05 USD and a high forecast of 10.5 USD.

What is ADC Therapeutics SA's Revenue forecast?
Projected CAGR
53%

For the last 7 years the compound annual growth rate for ADC Therapeutics SA's revenue is 85%. The projected CAGR for the next 3 years is 53%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett